Ecological association between residential natural background radiation exposure and the incidence rate of childhood central nervous system tumors in France, 2000-2012.


Journal

Journal of environmental radioactivity
ISSN: 1879-1700
Titre abrégé: J Environ Radioact
Pays: England
ID NLM: 8508119

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 30 04 2019
revised: 01 08 2019
accepted: 23 09 2019
pubmed: 11 10 2019
medline: 19 3 2020
entrez: 11 10 2019
Statut: ppublish

Résumé

High-dose ionizing radiation is an established risk factor for childhood central nervous system tumors (CNST) but the role of low doses remains debated. In particular, there are few studies of natural background radiation (NBR, gamma radiation and radon) and childhood CNST, and their results are inconclusive. This study aimed to investigate the ecological association between NBR exposure and childhood CNST incidence in France, considering childhood CNST overall and by subgroups. Incidence data were provided by the French national registry of childhood cancers, which has high completeness. We included 5471 childhood CNST cases registered over the period 2000-2012, and their municipality of residence at diagnosis was recorded. Municipality NBR exposures were estimated by cokriging models, using NBR measurements and additional geographic data. The incidence rate ratio (IRR) per unit variation of exposure was estimated with Poisson regression models. NBR exposures were considered at the time of diagnosis, and cumulatively from birth to diagnosis. In an exploratory analysis, the total brain dose due to NBR was used. Overall, there was no association between NBR exposure and childhood CNST incidence (IRR = 1.03 (0.98,1.09) per 50 nSv/h for gamma radiation, and IRR = 1.02 (0,96,1.07) per 100 Bq/m Our study was based on high quality incidence data, large numbers of CNST cases, and validated models of NBR exposure assessment. Results suggest an association between gamma radiation, as a component of NBR, and pilocytic astrocytomas incidence in France.

Sections du résumé

BACKGROUND BACKGROUND
High-dose ionizing radiation is an established risk factor for childhood central nervous system tumors (CNST) but the role of low doses remains debated. In particular, there are few studies of natural background radiation (NBR, gamma radiation and radon) and childhood CNST, and their results are inconclusive.
OBJECTIVES OBJECTIVE
This study aimed to investigate the ecological association between NBR exposure and childhood CNST incidence in France, considering childhood CNST overall and by subgroups.
METHODS METHODS
Incidence data were provided by the French national registry of childhood cancers, which has high completeness. We included 5471 childhood CNST cases registered over the period 2000-2012, and their municipality of residence at diagnosis was recorded. Municipality NBR exposures were estimated by cokriging models, using NBR measurements and additional geographic data. The incidence rate ratio (IRR) per unit variation of exposure was estimated with Poisson regression models. NBR exposures were considered at the time of diagnosis, and cumulatively from birth to diagnosis. In an exploratory analysis, the total brain dose due to NBR was used.
RESULTS RESULTS
Overall, there was no association between NBR exposure and childhood CNST incidence (IRR = 1.03 (0.98,1.09) per 50 nSv/h for gamma radiation, and IRR = 1.02 (0,96,1.07) per 100 Bq/m
CONCLUSIONS CONCLUSIONS
Our study was based on high quality incidence data, large numbers of CNST cases, and validated models of NBR exposure assessment. Results suggest an association between gamma radiation, as a component of NBR, and pilocytic astrocytomas incidence in France.

Identifiants

pubmed: 31600676
pii: S0265-931X(19)30348-0
doi: 10.1016/j.jenvrad.2019.106071
pii:
doi:

Substances chimiques

Radon Q74S4N8N1G

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

106071

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Justine Berlivet (J)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France. Electronic address: justine.berlivet@inserm.fr.

Denis Hémon (D)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France.

Énora Cléro (É)

Institut de Radioprotection et de Sûreté Nucléaire, IRSN, PSE-SANTE/SESANE, Fontenay aux Roses, F-92262, France.

Géraldine Ielsch (G)

Institut de Radioprotection et de Sûreté Nucléaire, IRSN, PSE-ENV/SEREN, Fontenay aux Roses, F-92262, France.

Dominique Laurier (D)

Institut de Radioprotection et de Sûreté Nucléaire, IRSN, PSE-SANTE/SESANE, Fontenay aux Roses, F-92262, France.

Sandra Guissou (S)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France; CHU Nancy, French National Registry of Childhood Solid Tumors (RNTSE), Faculté de Médecine, Vandoeuvre-lès-Nancy, F-54500, France.

Brigitte Lacour (B)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France; CHU Nancy, French National Registry of Childhood Solid Tumors (RNTSE), Faculté de Médecine, Vandoeuvre-lès-Nancy, F-54500, France.

Jacqueline Clavel (J)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France; French National Registry of Childhood Hematological Malignancies (RNHE), Villejuif, F-94807, France.

Stéphanie Goujon (S)

Inserm, UMR 1153 Epidemiology and Biostatistics Sorbonne Paris Cité Research Center (CRESS), Epidémiologie des Cancers de l'enfant et de l'adolescent Team (EPICEA), Villejuif, F-94807, France; Paris Descartes University, Sorbonne Paris Cité, France; French National Registry of Childhood Hematological Malignancies (RNHE), Villejuif, F-94807, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH